DEFA1 and COVID-19: This prospective observational study aimed to assess how serum 25(OH)D concentrations and nasopharyngeal expression of VDR, DEFA1-3, and CCL20 are associated with COVID-19 status in Lebanese participants tested between January and March 2024.